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affected DNA synthesis of OLETF or LETO MCs. LDL recep-Response of mesangial cells to low-density lipoprotein and
tors and scavenger receptors were predominant in y-OLETFangiotensin II in diabetic (OLETF) rats.
and o-OLETF, respectively. After stimulation with n-LDL andBackgound. Progression of diabetic nephropathy is closely
ox-LDL, expression of type I and type III collagen, along withassociated with morphological changes in glomeruli, such as
transforming growth factor- (TGF-), was higher in o-OLETFthickening of the glomerular basement membrane, mesangial
MCs that in y-OLETF MCs or LETO MCs. Exposure to Angexpansion, and glomerulosclerosis. To elucidate early glomeru-
II markedly induced DNA synthesis and ECM mRNA expres-lar events, we compared the mitogenic activity and extracellular
sion in y-OLETF MCs and o-OLETF MCs, respectively.matrix production in mesangial cells (MC) isolated from dia-
Conclusions. These findings indicate that the cell prolifera-betic rats prior to the manifestation of nephropathy and those
tion process precedes the evolution of diabetic glomerulopathy.showing overt nephropathy. This study may help to clarify
The responses of OLETF MCs to n-LDL/ox-LDL and Ang IIthe mechanisms underlying diabetic nephropathy and provide
differed depending on the stage of diabetes. In the early phase,clues about early therapeutic interventions for preventing or
MCs were prone to proliferate, whereas in the late stage, MCs,slowing this process.
which expressed higher levels of TGF-, tended to synthesizeMethods. Otsuka Long-Evans Tokushima Fatty (OLETF)
ECM. A functional switch in MCs may contribute to the devel-rats, a chronic model for human type 2 diabetes mellitus, and
opment of glomerulosclerosis in diabetic nephropathy.age-matched control (LETO) rats were used. Glomerular cell
numbers, expression of immediate early genes (c-Fos and
c-Myc) and proliferating cell nuclear antigen (PCNA), and
low-density lipoprotein (LDL) deposition were determined in Thirty to 50% of patients with juvenile- or mature-renal tissue sections from rats aged 15 to 75 weeks. Mesan-
onset diabetes mellitus develop clinically evident dia-gial cells (MCs) from OLETF rats at two different stages of
betic nephropathy 10 to 20 years from the onset of diabe-the disease, that is, young (12- to 14-week-old) OLETF rats
(y-OLETF) prior to the manifestation of nephropathy and old tes mellitus [1]. Thus, it is important to elucidate the
(48- to 50-week-old) OLETF rats (o-OLETF) showing ne- mechanisms involved in the progression of renal compli-
phropathy, were isolated and cultured. After stimulation with cations of this disease. Diabetic nephropathy is charac-native (n-) or oxidized (ox-) LDL or angiotensin II (Ang II),
terized by glomerular hypertrophy, extracellular matrixDNA synthesis and extracellular matrix (ECM) production
(ECM) accumulation in the mesangium, and thickeningwere examined. Cellular expression of LDL/scavenger recep-
tors was analyzed using fluorescence-labeled LDL and binding of glomerular capillary walls, leading to glomerulosclero-
to 125I-labeled-LDL. sis and loss of renal function [2, 3].
Results. The number of cells per glomerular cross section Rats administered streptozotocin or alloxan and ge-was significantly higher in OLETF rats than in LETO rats
netically selected animals fed a high-sucrose diet havebetween 25 and 65 weeks of age. In OLETF glomeruli, c-Fos,
been employed as the models for type 2 diabetes mellitusc-Myc, and PCNA were transiently expressed in the early
phase. Glomerular LDL deposition increased with the age of [4]. In this study, we used the Otsuka Long-Evans To-
OLETF rats. Addition of a low dose of n-LDL (10 g/mL) to kushima Fatty (OLETF) rat, which was developed from
the culture medium significantly stimulated DNA synthesis of a strain of Long-Evans rat by selective breeding and isy-OLETF MCs, as compared with o-OLETF MCs and LETO
now recognized as an adequate model for human typeMCs (P  0.05). A high dose of n-LDL (100 g/mL) caused
2 diabetes mellitus [5, 6]. The characteristic features ofcytotoxic effects in all cells. Exposure to ox-LDL minimally
OLETF rats are [5, 6] (1) a chronic course of diabetes;
(2) hyperlipidemia; (3) mild obesity; (4) male inheritance;Key words: glomerulosclerosis, oxidized LDL, extracellular matrix, hu-
(5) hyperplastic foci of pancreatic islets; and (6) renalman type 2 diabetes, cell proliferation, progressive renal disease, dia-
betic nephropathy. complications. In OLETF rats, plasma glucose levels are
high at 8 weeks of age and then significantly exceedReceived for publication March 13, 2001
that of the genetic controls, the Long-Evans Tokushimaand in revised form July 13, 2001
Accepted for publication August 20, 2001 Otsuka (LETO) rats, after 18 weeks of age. Hypercholes-
terolemia and hypertriglycemia appear at 8 weeks of 2002 by the International Society of Nephrology
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age, but deteriorate with age. OLETF rats past the age antibodies to rat collagen types I and III were from
Chemicon. Fetal calf serum (FCS) was purchased fromof 30 weeks show significant proteinuria compared with
LETO rats, and the proteinuria progressively increases HyClone (Logan, UT, USA). The following reagents
were purchased from Sigma (St Louis, MO, USA): Angwith time [5, 6]. Pathological changes of the kidney in
OLETF rats past the age of 40 weeks include ECM ac- II, trypsin, collagenase, RPMI 1640, Dulbecco’s modified
Eagle’s medium (DMEM), ampicillin-streptomycin solu-cumulation in the mesangium, thickening of the glomeru-
lar basement membrane, and glomerulosclerosis, changes tion, insulin, Nu-serum and fatty acid-free bovine serum
albumin (BSA). Salmon sperm DNA was obtained fromresembling human diabetic glomerulopathy [5, 6]. Thus,
this model is appropriate for observing the long-term Stratagene (Heidelberg, Germany). 50Denhardt’s so-
lution was purchased from Wako Pure Chemical Indus-disease course.
Several growth factors or metabolic products, includ- tries, Ltd. (Osaka, Japan).
ing transforming growth factor- (TGF-), insulin-like
Glomerular isolation and MC culturegrowth factor-I, platelet-derived growth factor, prosta-
glandins, angiotensin II (Ang II), low-density lipoprotein Mesangial cells were separated from glomeruli of male
OLETF rats according to the procedure described by(LDL) and advanced glycation end products, have been
shown to be contributing factors involved in the progres- Harper et al [10] as described in our earlier publications
[11, 12]. Animals at two different stages of the disease weresion of diabetic glomerulopathy [7–9]. These factors can
promote mesangial cell (MC) proliferation, glomerular selected: young rats (y-OLETF) prior to development of
nephropathy at 12 to 14 weeks of age and weighing 400hypertrophy, and ECM overproduction, or alter the glo-
merular hemodynamics. to 500 g, and old rats (o-OLETF) showing developed
nephropathy at 48 to 50 weeks of age that weighed 600The present study was performed to elucidate the early
events in the evolution of diabetic glomerulopathy. MCs to 700 g. Glomeruli were harvested by sieving the renal
cortices, which were then digested with 0.25% trypsin, fol-from OLETF rats at two different stages of the disease,
that is, MCs from young rats prior to development of lowed by incubation with 0.05% collagenase for 10 to 15
minutes each at 37C in culture chambers. As the primarynephropathy at 12 to 14 weeks old (y-OLETF MC) and
MC from old rats showing overt nephropathy at 48 to culture, the digested glomeruli were incubated at 37C
in RPMI 1640 supplemented with 20% FCS, 100 U/mL50 weeks old (o-OLETF MC), were compared with re-
spects to their response to native (n)-LDL/oxidized (ox)- ampicillin, 100 g/mL streptomycin and 0.6 U/mL insu-
lin. After two to three weeks, MCs appeared and obliter-LDL and Ang II.
ated the epithelial cells. Cultured cells were detached
with trypsin/ethylenediaminetetraacetic acid (EDTA),
METHODS
and glomeruli were removed by filtration. Mesangial
Animals and reagents cells were characterized by their typical stellate morphol-
ogy on light microscopy, positive staining for smoothAll procedures were in accordance with institutional
guidelines for animal research. Male OLETF rats and con- muscle-specific actin, and negative staining for factor
VIII antigen and for cytokeratin, as described previouslytrol male LETO rats were supplied by Otsuka Pharma-
ceutical Co., Ltd. (Tokushima, Japan). They were fed stan- [11, 12]. Mesangial cells from control LETO rats, 12 to
14 weeks old and weighing 400 to 450 g (y-LETO), ordard laboratory chow and given tap water ad libitum.
Human n-LDL and ox-LDL were purchased from Biogen- 48 to 50 weeks old and weighing 500 to 550 g (o-LETO),
also were cultured. LETO rats never became diabetic.esis (Sandown, NH, USA). n-LDL labeled with 1,1-dio-
actadecyl-3,3,3-tetramethylindocarbocyanine perchlorate MCs were expanded and passaged every seven days,
and the cells between the fifth and eighth passages were(Dil-n-LDL) and Dil-acetylated-LDL were from Biomed-
ical Technologies Inc. (Stoughton, MA, USA) and Harbor utilized in this study. The cells maintained the character-
istics of MCs described above. Confluent cells were madeBio-Products (Norwood, MA, USA), respectively. [125I]-
sodium salt, [3H]-thymidine and [32P]-dCTP were obtained quiescent by incubation in serum-free medium for 24 to
48 hours before the addition of test agents.from Amersham Japan (Tokyo, Japan). Rabbit antibody
to LDL (reactive with n-LDL, but not with ox-LDL) was
Assay of DNA synthesispurchased from Alpha Biomedical Laboratories (Belle-
vue, Washington, USA). Mouse antibody to proliferating Rat MCs, cultured in 24-well plastic plates until con-
fluence and starved in FCS-free RPMI 1640 for 48 hours,cell nuclear antigen (PCNA) was from Chemicon (Teme-
cula, CA, USA). Rabbit antibodies to c-Fos and c-Myc were incubated with n-LDL/ox-LDL, Ang II or FCS (for
baseline line culture) for the indicated times. [3H]-thymi-were from Oncogene Science (Cambridge, MA, USA).
Fluorescein isothiocyanate (FITC)-labeled goat anti- dine was added to the cultures at a final concentration
of 1 Ci/mL and the cultures were incubated for an ad-rabbit IgG and FITC-labeled goat anti-mouse IgG were
purchased from Cappel (Durham, NC, USA). Rabbit ditional four hours. The cells were rinsed three times
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with ice-cold phosphate-buffered saline (PBS) followed MCs were incubated in medium containing lipoprotein-
deficient serum consisting of DMEM supplemented withby incubation with 10% trichloroacetic acid for 30 min-
utes on ice. After rinsing with 100% ethanol, acid-precip- 1% FCS, 8% Nu-serum and 1% ampicillin-streptomycin
solution for 36 hours before the experiment. The mediumitable materials were dissolved in 0.25 N NaOH/0.1% so-
dium dodecyl sulfate (SDS) and counted by scintillation was then removed and replaced with 1 mL of medium
consisting of Dulbecco’s PBS with 100 mg% of glucose,spectrometry to determine the incorporation of [3H]-thy-
midine into the acid-insoluble cellular DNA fraction [13]. 2 mg/mL fatty acid-free BSA and [125I]-labeled n-LDL or
ox-LDL (1  106 CPM/mL). After incubation at 4C for
RNA isolation and Northern blot analysis the times indicated, the medium was removed, and the
Total RNA was extracted from cultured MC using Iso- MCs were washed three times with ice-cold PBS contain-
gen solution (Nippon Gene, Tokyo, Japan). Aliquots of ing 1% BSA. Additional solution was added to the cul-
15 g of RNA were electrophoresed in each lane, trans- ture plates, the plates were incubated for five minutes,
ferred onto S & S Nytran nylon membranes (Schleicher & and the solution was removed. Finally, cells were washed
Schuell, Keene, NH, USA), and fixed by exposure to with PBS without BSA. Then, the cells were osmolyzed
UV light (Funakoshi Ltd, Tokyo, Japan). The mem- in 1.0 N NaCl and radioactivity was counted with a
branes were prehybridized in a solution consisting of gamma counter.
50% formamide, 5  standard sodium citrate (SSC),
Incorporation of LDL into MCs0.5% (wt/vol) SDS, 5  Denhardt’s solution and 100
mg/mL sonicated salmon sperm DNA at 42C for at least Incorporation of LDL into MCs was examined using
a Dil-labeled fluorescent probe as described previouslyfour hours. Blots were then hybridized with 0.5 to 1.0 
107 cpm/mL of 32P-labeled cDNA probes at 42C for 12 [16]. Subconfluent MCs were incubated with Dulbecco’s
PBS with 100 mg% glucose and either 10 g/mL of Dil-to 18 hours. The cDNA probes used were the 1.3-kb PstI-
BamHI fragment of rat type I collagen, 2.23-kb EcoRI- n-LDL or Dil-acetylated-LDL at 37C for two hours. The
cells were washed vigorously with PBS and examined byBamHI fragment of rat type III collagen, rat trans-
forming growth factor- (a gift from Dr. Enyu Imai, The immunofluorescence microscopy.
First Department of Internal Medicine, Osaka Univer-
Morphological and immunohistological studiessity Graduate School of Medicine, Osaka, Japan) [14],
OLETF and LETO rats were sacrificed and studied atand 2.2-kb EcoRI fragment of matrix metalloproteinase
15, 25, 35, 45, 55, 65, and 75 weeks. Each group consisted(MMP)-2 (a gift from Dr. R.C. Harris, Department of
of five rats. The number of intraglomerular cells per glo-Medicine, Vanderbilt University School of Medicine,
merular cross-section was assessed by counting the totalNashville, TN, USA). Probes were labeled with 32P-dCTP
cell nuclei under a microscope using PAS-stained sections(108 cpm/g) by the random priming method using the
containing at least 20 equatorially cut glomeruli fromMegaprime DNA Labeling System (Amersham, Buck-
each animal, as described previously [17–19]. Indirectinghamshire, UK). After washing twice with 2  SSC
immunofluorescent staining was performed as describedfor 15 minutes at room temperature and with 1  SSC
previously [20, 21]. In brief, sections were reacted withcontaining 0.1% SDS for 15 minutes at 65C, and finally
the primary antibody followed by incubation with thewith 0.2% SSC containing 0.1% SDS for an additional
appropriate secondary antibodies labeled with FITC.15 minutes, the membranes were exposed to Amersham
As a control, kidney sections were incubated with non-Hyper-ECl film at 70C with intensifying screens. The
immune rabbit serum or unrelated mouse IgG antibody,blots were stripped and reprobed with a human glyceral-
followed by appropriate FITC-labeled secondary anti-dehyde-3-phosphate dehydrogenase (GAPDH) cDNA
bodies or secondary antibody alone. These controls gave(Clontech, Heidelberg, Germany) under the same condi-
entirely negative results. The sections containing at leasttions described above. Expression levels of mRNA were
20 glomeruli (N 	 5) were viewed under an immunoflu-quantified by densitometry and normalized relative to
orescent or a phase-contrast immunofluorescent micro-GAPDH expression. Data were presented as means 

scope (Nikon Eclipse E600, Tokyo, Japan) and the glo-SE of the ratios of optical density (OD) areas for
merular cells immunoreactive for PCNA, c-Fos, or c-MycmRNAs, divided by OD areas for GAPDH mRNA.
were counted, as described previously [18, 22]. The data
[125I]-LDL binding assay were expressed as the number of positive cells per glo-
[125I]-Low-density lipoprotein was prepared using a merular cross-section.
commercial kit (Iodo-Gen; Pierce, Rockford, IL, USA).
StatisticsFree [125I] was removed by gel filtration. The final radio-
activities ranged from 0.5 106 to 1 107 CPM/g LDL. Data are presented as mean
 SE. Statistical compari-
sons were performed using the Mann-Whitney U testThe LDL binding assay was carried out according to the
method described by Goldstein, Basu and Brown [15] with the software program StatView 4.5. P  0.05 was
considered statistically significant.with slight modifications [16]. After reaching confluence,
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Fig. 2. Immunofluorescent staining for type III collagen in OLETF
and LETO rat glomeruli. The accumulation of type III collagen was
evident in the mesangial areas in 45-week-old OLETF rats (B), but
much less evident in 15-week-old OLETF (A) and 45-week-old LETO
(C ) rats. A negative control section of a 45-week-old OLETF rat,
stained with non-immune rabbit serum, followed by FITC-labeled sec-
ondary antibodies, is shown in (D). Original magnifications were 400.
shown in Figure 1 A–E. In 15-week-old OLETF rats,
there were no obvious alterations in glomeruli. At 25
weeks of age, MC proliferation was observed. After 45
weeks, mesangial expansion accompanied by the accu-
mulation of ECM and thickening of glomerular capillary
walls occurred. At 65 weeks, fully developed diabetic
glomerulopathy accompanied by nodular sclerosis was
seen. In LETO rats, there were no obvious findings ex-
cept minor alterations due to aging in glomeruli even at
65 weeks.
ECM and LDL deposition in glomeruli of
OLETF rats
Glomerular deposition of LDL was weak in 15-week-
old OLETF rats, and it progressively increased from 25
to 65 weeks of age (Fig. 1 F–I). In LETO rat glomeruli,
Fig. 1. Microscopic findings (A–E) and low-density lipoprotein (LDL)
LDL was negative from 15 to 45 weeks of age and wasdeposition (F–J) in glomeruli of Otsuka Long-Evans Tokushima Fatty
(OLETF) and Long-Evans Tokushima Otsuka (LETO) rats. Glomeru- weakly deposited after 65 weeks of age (Fig. 1J). Type
lar changes were minimal in 15-week-old OLETF rats (A). An increase I and type III collagens were accumulated in the glomer-
of mesangial cells was seen in 25-week-old OLETF rats (B). ECM
uli in 45- to 65-week-old OLETF rats, but were notaccumulation was evident in 45-week-old OLETF rats (C) and “nodular
lesions” were present in 65-week-old OLETF rats (D), while only minor as extensively accumulated in the age-matched controls
glomerular changes were seen in 65-week-old LETO rats (E). Glomeru- (Fig. 2).
lar LDL deposition was seen in 15- (F) and 25-week-old (G) OLETF
rats. LDL deposition was intense in glomeruli of 45- (H) and 65-week-
Glomerular cell number and expression of PCNA,old (I) OLETF rats, whereas it was weak in glomeruli of 65-week-old
LETO rats (J). Original magnifications were 400. c-Fos and c-Myc in OLETF rats
Total glomerular cellularity and the glomerular cells
expressing PCNA, c-Fos and c-Myc were assessed using
RESULTS
kidney sections from OLETF and LETO rats (Fig. 3).
Morphology of glomeruli of OLETF rats Glomerular cell numbers were significantly higher in
OLETF rats from 25 to 65 weeks of age than in age-Representative light micrographs of glomeruli of
OLETF and control LETO rats of various ages are matched LETO rats. Glomerular cells expressing PCNA
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Fig. 3. Total glomerular cellularity and the
glomerular cells expressing PCNA, c-Fos and
c-Myc in OLETF rat kidneys. Immunofluo-
rescent staining for PCNA (a) and c-Myc (b)
in glomeruli of 35-week-old and 15-week-old
OLETF rats, respectively. Note the diffuse nu-
clear staining (arrows) within the glomeruli.
A negative control section, stained with non-
immune rabbit serum, followed by FITC-
labeled secondary antibodies, of 35-week-old
OLETF rat is shown in (c ). Arrowheads in
panels a to c denote the Bowman’s capsule; G is
glomerulus. Original magnifications were400.
Cell number (d) and expression of PCNA (e),
c-Fos (f), and c-Myc (g) in glomeruli of OLETF
() and LETO () rats. Glomerular cell num-
bers were significantly higher in OLETF than
in LETO rats between 25 and 65 weeks of
age (d). PCNA expression (e) in glomeruli was
significantly increased in 35-week-old OLETF
rats compared with that in LETO rats. The
number of glomerular cells expressing c-Fos (f)
and c-Myc (g) was significantly higher in 15-
week-old of OLETF rats than in LETO rats.
Total glomerular cells and glomerular cells pos-
itive for PCNA, c-Fos, and c-Myc were counted
in at least 20 glomeruli in each section (N 	 5
per group). Data are presented as mean 
 SE.
*P  0.05, **P  0.01.
were significantly increased in OLETF compared to 300% of control level. DNA synthesis in o-OLETF,
LETO rats at 35 week of age. Immunostaining revealed y-LETO and o-LETO MCs increased to 180 to 200% of
that the number of c-Fos- or c-Myc-positive glomerular the control level; the difference between y-OLETF MCs
cells was significantly higher in OLETF rats than in and o-OLETF or LETO MCs was significant (P  0.05).
LETO rats at 15 weeks of age. DNA synthesis in MCs from OLETF and LETO rats
was weakly stimulated by 50 g/mL of n-LDL. The addi-
Effects of LDL on DNA synthesis in cultured MCs tion of 100 g/mL of n-LDL suppressed DNA synthesis
In cultures of MCs in 10% FCS, the growth rate of in OLETF and LETO MCs, while the addition of 10
MCs from y-OLETF rats was similar to that of MCs g/mL, 50 g/mL, or 100 g/mL of ox-LDL minimally
from o-OLETF, y-OLETF and o-LETO rats for up to affected DNA synthesis in OLETF and LETO MCs.
48 hours. From 72 to 120 hours, the growth of MCs from
y-OLETF rats was faster, as shown by an approximately Analysis of LDL receptors/scavenger receptors in MC
1.6-fold increase in cell numbers compared with y- and
Incorporation of fluorescence-labeled n-LDL/acetyl-o-LETO MCs, and an approximately 1.3-fold increase
ated LDL and binding of 125I-labeled n-LDL/ox-LDL tocompared with o-OLETF MCs.
MCs were studied. After a two-hour incubation, fluores-Mesangial cells, cultured until confluent and starved
cence of Dil-n-LDL was strong in y-OLETF MCs, butin FCS-free medium for 48 hours, were incubated with
weak in o-OLETF or LETO MCs (Fig. 5A). Binding of10 g/mL, 50 g/mL, or 100 g/mL of n-LDL or ox-LDL
125I-labeled n-LDL to MCs reached equilibrium after one(Fig. 4). DNA synthesis evaluated by [3H]-thymidine in-
to two hours of incubation. The maximum binding tocorporation was compared between LDL-stimulated
y-OLETF MCs was approximately twofold greater thancells and unstimulated controls (	100%). The results
that to LETO MCs and fourfold greater than that toare expressed as the percent of the control DNA synthe-
o-OLETF MCs (Fig. 5B). Addition of excess amountssis. After exposure of MCs to 10 g/mL of n-LDL, DNA
synthesis in y-OLETF MCs increased to approximately of unlabeled n-LDL (100 g/mL) displaced approxi-
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Fig. 4. DNA synthesis in mesangial cells (MCs) exposed to native (n)-low-density lipoprotein (LDL)/oxidized (ox)-LDL. MCs were incubated
with 10 g/mL, 50 g/mL, or 100 g/mL of n-LDL or ox-LDL for 4 hours. The unstimulated basal level in young (y)-OLETF MCs (), old
(o)-OLETF ( ), y-LETO ( ), and o-LETO ( ) was 2.3 104 cpm, 0.8  104 cpm, 1.0  104 cpm, and 0.9  104 cpm, respectively. After stimulation
with 10 g/mL of LDL, [3H]-thymidine incorporation in y-OLETF, o-OLETF, y-LETO, and o-LETO was 7.0  104 (mean) cpm, 1.5  104 cpm,
2.1  104 cpm, and 1.9  104 cpm, respectively. y-OLETF MCs showed an approximately 300% increase from the unstimulated basal level,
compared with o-OLETF MCs (180% increase) or control LETO MC (200% increase). DNA synthesis in MCs from OLETF and LETO rats
was weakly stimulated by 50 g/mL of n-LDL, while 100 g/mL of n-LDL suppressed DNA synthesis in MCs from OLETF and LETO rats.
Exposure to 10 g/mL, 50 g/mL or 100 g/mL of ox-LDL did not markedly affect DNA synthesis in OLETF and LETO MCs. Symbols and
bars represent means 
 SE of 3 experiments, each carried out in quadruplicate; *P  0.05.
mately 40 to 50% of the 125I-labeled LDL in a time- elevated in o-OLETF MCs compared with y-OLETF or
LETO MCs after stimulation with 50 g/mL n-LDL ordependent manner.
Similarly, incorporation of fluorescence-labeled ace- ox-LDL (Fig. 8). Induction of MMP-2 mRNA by n-LDL/
ox-LDL was similar in y-OLEFT, o-OLETF, and LETOtylated-LDL and binding of 125I-labeled ox-LDL to MCs
were studied. Uptake of Dil-acetylated-LDL was high MCs (data not shown).
in o-OLETF MCs (Fig. 6A). The level of 125I-ox-LDL
Effects of Ang II on DNA synthesis andbinding was elevated in o-OLETF MCs (1.5-fold and 3
ECM production in MCto 4-fold higher in o-OLETF MCs than in y-OLETF
and LETO MCs, respectively). Exposure to Ang II (107 mol/L) caused a significantly
greater elevation of DNA synthesis in y-OLETF MCs
ECM production by MCs after stimulation (300% of control level in y-OLETF vs. 120 to 160% of
with n-LDL/ox-LDL control level in o-OLETF, y-LETO and o-LETO, P 
Type I and type III collagen synthesis in MCs after 0.05; Fig. 9). Northern blot analyses for type I and III
stimulation with 50 g/mL of n-LDL or ox-LDL was ana- collagen mRNA revealed that ECM production was high
lyzed by Northern blotting (Fig. 7). In o-OLETF MCs, in unstimulated o-OLETF MCs and was further in-
type I collagen mRNA expression was up-regulated af- creased after incubation with Ang II (Fig. 10A), while
ter addition of n-LDL or ox-LDL. y-OLETF MCs and there was no marked increase in y-OLETO or LETO.
LETO MCs showed only a slight increase in type I col- After stimulation of MCs with Ang II, TGF- mRNA
lagen mRNA levels. Similar results were observed for was also more markedly up-regulated in o-OLETF MCs
type III collagen mRNA expression in these cells (data than in MCs from y-OLETF or LETO rats (Fig. 10B).
not shown).
DISCUSSIONInduction of TGF- mRNA and MMP-2 mRNA
expression by n-LDL/ox-LDL Using OLETF rats, which exhibit chronic-course dia-
betes resembling human type 2 diabetes mellitus, we foundNorthern blot analyses revealed that TGF- mRNA
a significant increase in glomerular cell number in OLETFexpression in MCs from OLETF and LETO rats was
minimal in untreated cultures in FCS, but was markedly compared to LETO rats between 25 and 75 weeks of
Fig. 5. Uptake of fluorescence-labeled n-LDL into cultured MCs and binding of 125I-labeled n-LDL to cultured MCs. Dil-n-LDL-uptake (a) and
binding to 125I-labeled n-LDL (b) were higher in y-OLETF MCs (c) than in o-OLETF or LETO MCs. Symbols and bars and bars represent
means 
 SE of 3 experiments, each carried out in quadruplicate. Symbols in panel d are: () y-OLETF; () y-LETO; () o-LETO; () o-OLETF.
Fig. 6. Uptake of fluorescence-labeled modified LDL into cultured MCs and binding of 125I-labeled ox-LDL to cultured MCs. Dil-acetylated-LDL
uptake (a) and 125I-labeled ox-LDL binding (b) were elevated in o-OLETF MCs compared with y-OLETF or LETO MCs. Symbols and bars and
bars represent means 
 SE of 3 experiments, each carried out in quadruplicate. Symbols in panel d are: () o-OLETF; () y-OLETF; ()
o-LETO; () y-LETO.
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Fig. 7. Type I collagen mRNA expression in
MCs after exposure to n-LDL or ox-LDL. (A)
Northern blots of representative experiments
and (B) the ratio of optical density (OD) areas
for type I collagen mRNA divided by OD
areas for DAPDH mRNA. Symbols and bars
represent means 
 SE of 3 experiments, each
carried out in quadruplicate. After exposure
to 50 g/mL of n-LDL or ox-LDL, type I
collagen mRNA expression in o-OLETF MCs
was up-regulated and peaked within 2 to 8
hours of incubation (right panel). Type I colla-
gen mRNA expression was only slightly in-
creased in y-OLETF MCs (left panel) and
OLETO MCs (data not shown) after stimula-
tion with n-LDL or ox-LDL.
age. Glomerular cells in OLETF rats in the early stage immediate early genes (c-fos, c-myc, and Egr-1), tran-
scriptional factors that are expressed in the G1 phase ofshowed transient up-regulation of PCNA as well as of
the immediate early gene products c-Fos and c-Myc. the cell cycle [29], have been studied in diabetic models
[27, 30, 31] and MCs cultured in high-glucose media [32].Previous studies investigating glomerular cell prolifera-
tion in the early phase of diabetes reported conflicting Increased expression of PCNA has been reported in glo-
merular cells from rats with streptozotocin-induced dia-results. Earlier morphological observations performed
using kidneys from patients with type I diabetes mellitus betes [19, 30]. Young et al observed early and self-limited
MC proliferation in this model, and showed that staining[23, 24] or streptozotocin-induced diabetic rats [25] re-
vealed glomerular hypertrophy and basement membrane for PCNA was evident by day 1, and peaked at day 3
[19]. PCNA as well as immediate early genes (c-myc andthickening as the initial structural alterations. Subse-
quent detailed studies using autoradiography indicated Egr-1) were induced in MCs cultured in high glucose
conditions [32]. Transient increases in c-fos and c-junthat glomerular hypercellularity occurs concomitantly
with glomerular enlargement in the early phase of strep- were reported after the onset of hyperglycemia in dia-
betic rats [31]. Thus, our data, together with those oftozotocin-induced diabetes in rats [26]. Mahadevan et al
reported a significant increase in the number of MC in others [19, 27, 30–32], indicate that proliferation of glo-
merular cells occurs in the diabetic milieu preceding therats 21 days after induction of streptozotocin-induced
diabetes [27]. PCNA, a nuclear protein that is maximally development of nephropathy.
Abnormal lipid metabolism is a frequent complicationactivated during the S-phase of the cell cycle [28], and
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whereas the LDL receptor in o-OLETF rats appeared
to be down-regulated. These observations suggest that,
in addition to LDL binding to its specific receptor, other
mechanisms, such as affinity of LDL to glycosaminogly-
cans in glomerular matrix components [43] or phagocyto-
sis of LDL by mesangial cells [44], are involved in glo-
merular LDL deposition.
Young-OLETF MCs, expressing high levels of LDL
receptors, markedly proliferated after exposure to low
concentrations (10 g/mL) of n-LDL. In contrast, prolif-
erative response to this dose of n-LDL in o-OLETF MCs
was similar to that in LETO MCs. It has been shown
that low concentrations of LDL induce proliferation of
rat MCs but high concentrations (100 g/mL) of it are
instead cytotoxic [45], as we found in OLETF and LETO
MCs. It is generally considered that LDL concentrations
of 100 to 500 g/mL are well within the physiological
range in the plasma of non-diabetic rats [45]. In OLETF
rats that develop hyperlipidemia after 8 weeks of age
[6], the plasma lipoprotein levels are expected to be in-
creased with age. It is unknown, however, what the pre-
Fig. 8. Transforming growth factor- (TGF-) mRNA expression in
vailing concentration of LDL is for mesangial cells in vivo,MCs treated with n-LDL/ox-LDL. (A) Northern blot analysis showed
that, after 18 hours of incubation with 50 g/mL of ox-LDL, TGF- because the passage of LDL particles into the mesangial
mRNA expression was higher in o-OLETF MCs than in y-OLETF or area may be influenced by the accessibility to fenestrated
LETO MCs. (B) The ratio of TGF-mRNA signal to GAPDH mRNA
endothelium and by charged endothelium [45].signal in OLETF and LETO MCs with stimulation by 50 g/mL of
n-LDL ( ) or ox-LDL () or or without stimulation of LDL (). n- Oxidized-LDL is produced by conversion from n-LDL
LDL and ox-LDL significantly increased TGF- mRNA expression in by free radicals excreted by macrophages or intrinsic glo-
o-OLETF, compared with y-OLETF (P  0.01) and o-LETO (P 
merular cells [33, 46–48]. Cultured MCs from non-diabetic0.01). Symbols and bars represent means 
 SE of 3 experiments, each
carried out in quadruplicate; **P  0.01. rats have been demonstrated to bind and incorporate ox-
LDL to a greater extent than n-LDL [41], which results
in the alterations of eicosanoid synthesis and cytokine
production, influencing local glomerular hemodynamics,
in various types of immune-mediated or nonimmune- vascular permeability and ECM production [41, 49]. LDL
mediated glomerular diseases [33, 34]. Previous studies binding studies indicated that y-OLETF MCs possess a
in humans and animals have suggested that altered lipid relatively low concentration of scavenger receptors com-
metabolism causes glomerular injury and promotes dete- pared with LDL receptors, which may be related to the
rioration of glomerular function [35, 36]. Hypercholes- poor response of DNA synthesis to ox-LDL. In contrast,
terolemia and hypertriglycemia, commonly observed o-OLETF MCs expressed high amounts of scavenger re-
during the course of human diabetes mellitus [37], are ceptors and showed the down-regulation of LDL receptors.
also found in OLETF rats [5, 6]. Quantitative abnormali- Following stimulation with n-LDL or ox-LDL, o-OLETF
ties of the major cholesterol carrier LDL as well as quali- MCs produced ECM proteins, while y-OLETF synthe-
tative alterations of LDL such as enhanced glycation and sized rather small amounts of these proteins. It appears
oxidation have been implicated in diabetic microvascular that functional changes of MCs with respect to the re-
complications [38, 39]. Glomerular cells, including MCs sponse to n-LDL/ox-LDL occur with the development
and epithelial cells, possess LDL receptors, and thus of diabetes in OLETF rats. Although the precise mecha-
are affected by abnormal lipid metabolism [16, 40]. In nisms of the functional switch in OLETF MCs are un-
addition, MCs can express scavenger receptors [21, 41]. clear, the switch may be explained by a transition from
As shown for the development of atherosclerosis [42], cellular expression of LDL receptors to expression of scav-
glomerular cells can be damaged by the uptake of n-LDL enger receptors and also by co-expression of TGF- in
or ox-LDL via their specific receptors. o-OLETF MCs, but not in y-OLETF MCs. Furthermore,
We studied the glomerular LDL deposition and the it is speculated that the intracellular signaling processes
response of OLETF MCs to n-LDL or ox-LDL. In this are different in MCs from y-OLETF and o-OLETF rats.
model, plasma levels of cholesterol and triglyceride in- Stimulation by n-LDL or modified LDL has been reported
creased from 8 weeks of age [5, 6]. We found that glomer- to induce activation of extracellular signal-regulated ki-
nases (ERK), one of the mitogen-activated protein kinaseular LDL deposition progressively increased with age,
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Fig. 9. DNA synthesis in OLETF and LETO
MCs exposed to angiotensin II (Ang II 107
mol/L) for 18 hours. [3H]-thymidine incorpo-
ration was high in unstimulated y-OLETF
MCs, and was further increased by exposure
to Ang II, while it was low in o-LETF and
LETO MCs with or without Ang II exposure.
Symbols and bars represent means 
 SE of 5
separate experiments (N 	 3 rats per group);
**P  0.01.
signaling pathways, in non-diabetic rat MCs [50], which
affects cell proliferation and also matrix production. The
activation of this pathway may contribute to MC prolifer-
ation or ECM synthesis in diabetic conditions as well.
Gene induction downstream of the ERK cascade might
be different in y-OLETF and o-OLETF rats, thus induc-
ing different responses to the same stimulus.
Various lines of evidence indicate that the renin-angio-
tensin system is locally activated in diabetic nephropathy,
thus influencing parenchymal cell functions and hemody-
namics in the kidney [51, 52]. In several human studies,
angiotensin-converting-enzyme inhibitors or Ang II re-
ceptor blockades have been demonstrated to be renopro-
tective, independent of their systemic antihypertensive
actions [53, 54]. Ang II contributes to control of hyper-
trophy, DNA synthesis and ECM production in glomeru-
lar cells [9, 52, 55]. These actions are exerted in part by
synergy with other growth factors such as TGF- or by
co-inhibition of proteolytic enzymes to retard the degra-
dation of ECM [9, 56]. In this study, y-OLETF MCs stim-
ulated with Ang II showed a significant increase in DNA
synthesis compared with o-OLETF and LETO MCs. In
contrast, o-OLETF MCs stimulated with Ang II pro-
duced type I and type III collagen and showed the en-
hancement of TGF- expression, whereas ECM synthe-
sis was not markedly affected by Ang II in y-OLETO
and LETO MCs. The precise mechanisms of the shift
from cell proliferation toward ECM production in AngFig. 10. Northern blot analysis for type I and III collagen mRNA (A)
and TGF- mRNA (B) in Ang II-stimulated MCs from OLETF and II-stimulated MCs are unclear. In the late stage of diabe-
LETO rats. (A) Incubation with Ang II (Ang II) resulted in up- tes in OLETF rats, prolonged hyperglycemia or otherregulation of type I and III collagen mRNAs in o-OLETF MCs, but
metabolic abnormalities might facilitate expression ofnot in y-OLETF and LETO MCs. (B) After incubation of MCs with
Ang II, TGF- mRNA expression was stronger in o-OLETF MCs than other relevant growth factors such as TGF-. Similar to
in y-OLETF or o-LETO MCs. In untreated MC cultures in FCS, TGF- our findings, Yagi et al reported that, in OLETF rats,mRNA expression was minimal in OLETF and LETO rats (as shown
in Fig. 8B). glomerular type I collagen mRNA and TGF- mRNA
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apoptosis of rat mesangial cells in culture. Clin Exp Nephrol 2:12–were up-regulated at diabetic stage (30- and 54-weeks-
17, 1998
old), but not at the prediabetic stage (14-weeks-old) [57]. 12. Takemura T, Murata Y, Hino S, et al: Heparin-binding EGF-
like growth factor is expressed by mesangial cells and involved inPrevious reports [19, 27, 30–32, 57] and our present find-
mesangial proliferation in glomerulonephritis. J Pathol 189:431–ings collectively indicate that stage-specific gene regula-
438, 1999
tion is induced in multipotential MCs of diabetic rats. 13. Takemura T, Kondo S, Homma T, et al: The membrane-bound
form of heparin-binding epidermal growth factor-like growthThe precise mechanisms of this process has not been fully
factor promotes survival of cultured renal epithelial cells. J Biolelucidated, but expression of specific receptors, as ob-
Chem 272:31036–31042, 1997
served in n-LDL/ox-LDL, coexpression of TGF-, as we 14. Akagi Y, Isaka Y, Arai M, et al: Inhibition of TGF expression
by antisense oligonucleotides suppressed extracellular matrix accu-found in o-OLETF MCs stimulated with ox-LDL and
mulation in experimental glomerulonephritis. Kideny Int 50:148–Ang II, and other mechanisms such as different activa-
155, 1996
tion or control of genes downstream of intracellular sig- 15. Goldstein J, Basu S, Brown M: Receptor-mediated endocytosis
of low-density lipoprotein in cultured cells. Methods Enzymol 98:nals in y-OLETF and o-OLETF rats may be involved.
241–260, 1983In summary, our observations showed that, upon stim-
16. Wasserman J, Santiago A, Rifici V, et al: Interactions of low
ulation with n-LDL/ox-LDL and Ang II, functional density lipoprotein with rat mesangial cells. Kidney Int 35:1168–
1174, 1989transformation from proliferation to ECM biosynthesis
17. Floege J, Burns M, Alpers C, et al: Glomerular cell proliferationoccurred in cultured OLETF MCs during the evolution
and PDGF expression precede glomerular sclerosis in the remnant
of diabetes. The status of these elements in diabetic kidney model. Kidney Int 41:297–309, 1992
18. Takemura T, Okada M, Akano N, et al: Proto-oncogene expres-conditions in vivo remain speculative, but in vitro experi-
sion in human glomerular diseases. J Pathol 178:343–351, 1996ments using cultured MCs may reflect certain processes
19. Young B, Johnson R, Alpers C, et al: Cellular events in the
of abnormal regulation of proliferation and ECM pro- evolution of experimental diabetic nephropathy. Kidney Int 47:
935–944, 1995duction in vivo. Further studies are needed to demon-
20. Yoshioka K, Takemura T, Murakami K, et al: Transformingstrate that intervention with agents modifying MC re-
growth factor- protein and mRNA in glomeruli in normal and
sponses in the early phase can retard or prevent the diseased human kidneys. Lab Invest 68:154–163, 1993
21. Takemura T, Yoshioka K, Aya N, et al: Apolipoproteins andprogression of diabetic nephropathy.
lipoprotein receptors in glomeruli in human kidney diseases. Kid-
ney Int 43:918–927, 1993
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